Researchers in Germany say they have directly converted aged blood-cell precursors into induced neural stem cells (iNSCs) that show molecular signs of rejuvenation — a finding that, if replicated and extended, could affect how scientists approach ageing and regenerative therapies.
Direct conversion skips embryonic stage
The team at the University Hospital of Bonn and the University of Bonn used a direct conversion strategy to turn erythroid progenitor cells (EPCs) — immature precursors to red blood cells — into neural stem cells without reverting them to a pluripotent embryonic‑like state first. That approach contrasts with the more circuitous route in which cells are reprogrammed back to a pluripotent stage and then differentiated into a new cell type.
To induce the transformation, researchers relied on a viral vector to deliver two transcription factors — proteins that regulate gene activity — to the EPCs. The resulting cells were characterised with multiple molecular assays to assess both identity and age-related signatures.
"Using this method, we have directly converted red blood cell precursors into neural stem cells,"
The work, published in the journal Aging Cell, used donor material from 15 people spanning the human lifespan. Donors ranged from newborn to 101 years of age, enabling the team to examine how the donor’s chronological age influenced the reprogrammed cells.
Molecular measures point to rejuvenation
Investigators tracked cellular identity and ageing using two different genomic approaches: DNA methylation profiling and RNA sequencing. DNA methylation patterns are widely used as a biomarker of cellular age, while RNA sequencing reveals which genes are active and at what levels.
According to the report, the iNSCs derived from older donors carried molecular hallmarks indicating a shift toward a younger neural-stem-cell state. Moreover, as the cells were maintained in culture, those molecular markers continued to move in a direction consistent with rejuvenation rather than accumulating features of ageing.
- Cell source: erythroid progenitor cells (EPCs) from blood.
- Method: direct conversion via viral delivery of two transcription factors.
- Donor ages: newborn to 101 years (15 individuals).
- Analyses: DNA methylation clocks and RNA sequencing to assess age and cell identity.
Implications and cautions
The findings suggest two main points of interest for researchers. First, direct lineage conversion can produce neural stem cells from adult blood-derived precursors, potentially offering a more straightforward route to patient-specific neural cells than induced pluripotent stem cell (iPSC) methods. Second, and strikingly, those reprogrammed cells appear to reset some molecular indicators of ageing.
These observations are important for regenerative medicine because age-related cellular damage is a major obstacle to transplant or disease-modelling strategies that use patient-derived cells. If reprogrammed cells can be made to exhibit younger molecular profiles, they may be more resilient or have greater regenerative capacity.
However, the report in Aging Cell is focused on molecular signatures and in vitro behaviour. Whether those changes translate into functional advantages in vivo — for example, enhanced survival, integration, or repair capacity in the brain — requires further study. Safety also remains paramount: the method used a virus to deliver transcription factors, and any path to clinical application would need to address insertional risks and potential for uncontrolled growth.
What comes next
Future work will need to determine whether these iNSCs behave like native neural stem cells in animal models, whether rejuvenation is durable over long culture periods or after transplantation, and whether alternate delivery methods can achieve similar results without viral vectors.
| Feature | Reported detail |
|---|---|
| Donor sample size | 15 individuals |
| Donor age range | Newborn to 101 years |
| Source cell type | Erythroid progenitor cells (EPCs) |
| Converted cell type | Induced neural stem cells (iNSCs) |
The study adds to a growing body of work exploring how cellular identity and ageing can be modulated. It opens avenues for research but does not yet change clinical practice. Translational steps will depend on reproducibility, detailed functional assessment and rigorous safety evaluation.
For now, the research offers a provocative glimpse at how some hallmarks of cellular age might be reversed during direct reprogramming — a line of inquiry that could reshape thinking about ageing and repair in the decades to come.
